MABTAS N 100MG INJ is a Schedule H drug. MABTAS N 100MG INJ is composed of: RITUXIMAB (100.0 MG)
Tag: medicine for rheumatoid arthritis
MABTAS 500MG INFUSION
MABTAS 500MG INFUSION is a Schedule H drug. MABTAS 500MG INFUSION is composed of: RITUXIMAB (500.0 MG)
MABTAS 10MG INFUSION
MABTAS 10MG INFUSION is a Schedule H drug. MABTAS 10MG INFUSION is composed of: RITUXIMAB (10.0 MG)
MABALL 500MG INJ
MABALL 500MG INJ is a Schedule H drug. MABALL 500MG INJ is composed of: RITUXIMAB (500.0 MG)
MABALL 100MG INJ
MABALL 100MG INJ is a Schedule H drug. MABALL 100MG INJ is composed of: RITUXIMAB (100.0 MG)
LYZOHEAL D TAB
LYZOHEAL D TAB is a Schedule H drug. LYZOHEAL D TAB is composed of: BROMELAIN ( ), DICLOFENAC SODIUM ( ), RUTOSIDE ( ), TRYPSIN ( )
LYTIX DP 10MG/15MG TAB
LYTIX DP 10MG/15MG TAB is a Schedule H drug. LYTIX DP 10MG/15MG TAB is composed of: PARACETAMOL (15.0 MG), DICLOFENAC SODIUM (10.0 MG)
LYTIX D 50MG/10MG TAB
LYTIX D 50MG/10MG TAB is a Schedule H drug. LYTIX D 50MG/10MG TAB is composed of: DICLOFENAC SODIUM (50.0 MG), SERRATIOPEPTIDASE (10.0 MG)
LYTIC K TAB 50MG/10MG
LYTIC K TAB 50MG/10MG is a Schedule H drug. LYTIC K TAB 50MG/10MG is composed of: DICLOFENAC SODIUM (50.0 MG), SERRATIOPEPTIDASE (10.0 MG)
LYTIC K PLUS TAB
LYTIC K PLUS TAB is a Schedule H drug. LYTIC K PLUS TAB is composed of: PARACETAMOL (325.0 MG), DICLOFENAC SODIUM (50.0 MG), SERRATIOPEPTIDASE (10.0 MG)